Hairy cell leukemia - microscopic view
Hairy cell leukemia - microscopic view
Formed elements of blood
Formed elements of blood
Enlarged spleen
Enlarged spleen

Hairy cell leukemia

Definition:

A cancer of lymphocytes (B cells) that leads to low blood counts.



Alternative Names:
Leukemic reticuloendotheliosis; HCL

Causes, incidence, and risk factors:

Hairy cell leukemia (HCL) is an uncommon cancer of the blood. It can be one of the causes of low numbers of normal blood cells. The disease is caused by the abnormal growth of B cells that can look "hairy" under the microscope because they have fine projections coming from their surface.

The cause of this disease is unknown. It affects men 5 times more often than women, and the average age of onset is 55. Hairy cell leukemia is rare and only accounts for about 2% of the leukemias diagnosed each year.

Symptoms:
Signs and tests:
Treatment:

Early in the course of the disease, no treatment may be necessary. Some patients may need an occasional blood transfusion.

If treatment is needed because of very low blood counts, a variety of chemotherapy drugs (cladribine, pentostatin) can be used. Interferon is also used. In the majority of cases these drugs can produce a remission (complete relief from the disease) that lasts for many years. It is unclear if chemotherapy will cure the disease, however, because most patients will relapse over time.

The removal of the spleen may improve blood counts, but is unlikely to cure the disease.

Symptomatic treatment of infections with antibiotics or low blood counts with growth factors and transfusions may be required.

Expectations (prognosis):
Newer treatments using chemotherapy have greatly improved the survival of patients with hairy cell leukemia. Most patients with hairy cell leukemia can expect to live 10 years or longer with the disease.
Complications:
The low blood counts caused by hairy cell leukemia can lead to infections, fatigue, and excessive bleeding.
Calling your health care provider:
Call your health care provider if significant bleeding occurs. Also call if signs of infection are present, including: persistent fever, cough, or general ill feeling.
Prevention:
There is no known prevention.

Review Date: 2/9/2002
Reviewed By: William Matsui, M.D., Department of Oncology, Johns Hopkins Hospital, Baltimore, MD. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.